Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Cor Therapeutics describes selective factor Xa inhibitors

July 8, 1998

PDE V inhibitors for heart failure, impotence claimed by Merck KGaA

July 8, 1998

Investigation at Kowa results in development of potent CysLT1 receptor antagonists

July 7, 1998

Series of MMP and TACE inhibitors patented by American Cyanamid

July 7, 1998

ACAT inhibitors from SS Pharm. for atherosclerosis

July 7, 1998

Taisho claims potent and selective D4 receptor antagonists

July 7, 1998

Carcinostatic agents developed at Toagosei

July 7, 1998

Novel antitumor agent discovered by Banyu

July 7, 1998

HIV protease inhibitors developed by research group at Sankyo

July 7, 1998

Toyama describes novel cephalosporins for oral administration

July 6, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 5, 2025.
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Study identifies CAND1 as therapeutic target in hepatoblastoma
BioWorld Science
Hepatoblastoma is the most common liver cancer during childhood, with limited therapeutic options in aggressive or relapsed cases. NEDDylation is a...